Short form equity change report
Name of listed company: Daan Gene Co.Ltd(002030) place of stock listing: Shenzhen Stock Exchange
Stock abbreviation: Daan Gene Co.Ltd(002030)
Stock Code: 002030
Information disclosure obligor: Guangzhou Financial Holding Group Co., Ltd
Address: room 2601-2624, 26th floor, block B, Sinopec building, No. 191 TIYU West Road, Tianhe District, Guangzhou
Mailing address: 26 / F, Tower B, Sinopec building, No. 191, TIYU West Road, Tianhe District, Guangzhou. Nature of equity change: increase in the number and proportion of shares held
February, 2002
Statement of information disclosure obligor
1、 This report is prepared by the information disclosure obligor in accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the measures for the administration of the acquisition of listed companies, the standards for the content and format of information disclosure by public securities companies No. 15 – Report on changes in equity and other relevant laws, regulations and normative documents.
2、 The information disclosure obligor has obtained necessary authorization and approval for signing this report, and its performance does not violate or conflict with any provision in the articles of association or internal rules of the information disclosure obligor.
3、 In accordance with the securities law of the people’s Republic of China and the measures for the administration of the acquisition of listed companies, this report has fully disclosed the changes in the shares in which the information disclosure obligor has interests in Daan Gene Co.Ltd(002030) ;
As of the signing date of this report, except for the information disclosed in this report, the information disclosure obligor has not increased or reduced its shares in Daan Gene Co.Ltd(002030) by any other means. 4、 This equity change is based on the information stated in this report. The information disclosure obligor has not entrusted or authorized any other person to provide information not listed in this report and make any explanation or explanation to this report.
5、 The information disclosure obligor promises that there are no false records, misleading statements or major omissions in this report, and will bear individual and joint legal liabilities for its authenticity, accuracy and completeness.
catalogue
The disclosure obligor declares that 1 interpretation Section 1 Introduction to information disclosure obligors 4 Section 2 purpose of equity change Section III equity change method Section IV trading of shares of Listed Companies in the first six months Section V other major matters Section VI documents for future reference 13. The disclosure obligor declares that 14 attached table short form equity change report – Daan Gene Co.Ltd(002030) sixteen
interpretation
In this report, unless otherwise specified, the following abbreviations have the following specific meanings: This report / equity change report refers to the information disclosure obligor of Daan Gene Co.Ltd(002030) simplified equity change report and Guangzhou financial holding
Guangzhou Financial Holding Group Co., Ltd
Group and transferee
Daan Gene Co.Ltd(002030) . Listed company refers to Daan Gene Co.Ltd(002030)
Guangzhou bioengineering Center Co., Ltd., a wholly-owned subsidiary of the information disclosure obligor, refers to the bioengineering center and the transferor
company
The transfer of the wholly-owned interests of the group’s biological engineering center to the wholly-owned subsidiaries of the group
Daan Gene Co.Ltd(002030) 5% shares are transferred to their direct holding free of charge
China Securities Regulatory Commission
Yuan and 10000 yuan refer to RMB yuan and 10000 yuan
Special note: the data listed in this report may be slightly different from the sum directly added according to the relevant single data due to rounding.
Section I Introduction to information disclosure obligors
1、 Basic information of information disclosure obligor
Company name: Guangzhou Financial Holding Group Co., Ltd
Registered address: room 2601-2624, floor 26, block B, Sinopec building, No. 191 TIYU West Road, Tianhe District, Guangzhou
Legal representative: Nie linkun
Unified social credit code 91440101797354980n
Company type: limited liability company (state-owned holding)
The registered capital is 9479786472 yuan
Date of establishment: December 15, 2006
Business term: from December 15, 2006 to no fixed term
Business scope: self owned capital investment of the enterprise; Asset management (excluding license approval items); Investment advisory services; Investment management services
Name and shareholding ratio of shareholders: 90.51% held by Guangzhou Municipal People’s government and 9.49% held by Guangdong Provincial Department of Finance
Mailing address: 26th floor, Tower B, Sinopec building, No. 191, TIYU West Road, Tianhe District, Guangzhou
Postal Code: 510620
Tel: 020-38081160
2、 Information about the directors and main responsible persons of the information disclosure obligor
As of the signing date of this report, the basic information of the directors and main principals of the information disclosure obligor is as follows:
Name position gender Nationality Date of birth permanent residence right of residence in other countries or regions
Nie linkun, Secretary of the Party committee, male, China, Guangzhou, June 1965
chairman
Liang Yu, general manager and Deputy male, China December 1969 Guangzhou no
chairman
Deputy Secretary of the Party committee
Ma zhibinji, male trade union leader, Guangzhou, China, August 1966
Seats and directors
Li Zhiming, external director, male, China, October 1965, Guangzhou no
Peng Biyu, external director, male, China, January 1966, Guangzhou no
Xing Yiqiang, external director, male, China, June 1962, Guangzhou no
3、 Information disclosure obligors holding and controlling other listed companies
As of the signing date of this report, the shares in which the information disclosure obligor has interests in other listed companies at home and abroad have reached or exceeded 5% of the issued shares are shown in the following table:
Company name securities abbreviation securities code controlled number of shares controlled share ratio (share) example
Shenzhen Shenzhen Prolto Supply Chain Management Co.Ltd(002769) supply chain Shenzhen Prolto Supply Chain Management Co.Ltd(002769) 002769 39810538 10.67%
Management Co., Ltd
Remarks: Guangzhou financial holding group controls Shenzhen Prolto Supply Chain Management Co.Ltd(002769) 20066931 shares through its holding subsidiary Guangzhou financial holding green gold investment Co., Ltd., accounting for 5.38% of its total share capital, and Shenzhen Prolto Supply Chain Management Co.Ltd(002769) 19743607 shares through its holding subsidiary Shenzhen juzhitong Information Technology Co., Ltd., accounting for 5.29% of its total share capital.
Section 2 purpose of equity change
1、 Purpose of this equity change
This equity change is a free transfer of state-owned assets carried out by Guangzhou financial holding group to promote the integration of relevant state-owned assets, improve the liquidity of state-owned assets and promote the maintenance and appreciation of state-owned assets. After the implementation of this transfer, the total Daan Gene Co.Ltd(002030) shares controlled by Guangzhou financial holding group through direct and indirect means will not change. 2、 Shareholding plan of information disclosure obligor in the next 12 months
As of the signing date of this report, the information disclosure obligor has no clear plan to continue to increase the shares of the listed company or dispose of the shares in which it has interests in the next 12 months.
In the next 12 months, if the information disclosure obligor makes a decision to increase or dispose of the shares of the listed company, it will perform the information disclosure obligation in strict accordance with the securities law of the people’s Republic of China, the measures for the administration of the acquisition of listed companies and other relevant laws and regulations.
Section III changes in equity
1、 Method of this equity change
Before this equity change, the information disclosure obligor did not directly hold Daan Gene Co.Ltd(002030) shares; Indirectly holding Daan Gene Co.Ltd(002030) 233391995 shares through Guangzhou Zhongda Holding Co., Ltd., accounting for 16.63% of the total share capital of Daan Gene Co.Ltd(002030) ; Indirectly holding Daan Gene Co.Ltd(002030) 210516909 shares through bioengineering center, accounting for 15.00% of the total share capital of Daan Gene Co.Ltd(002030) ; To sum up, the information disclosure obligors control Daan Gene Co.Ltd(002030) 443908904 shares in total, and the types of shares are non tradable A shares, accounting for 31.63% of the total share capital of Daan Gene Co.Ltd(002030) .
This equity change is a free transfer of state-owned equity. The information disclosure obligor transfers Daan Gene Co.Ltd(002030) 70172302 shares directly held by its wholly-owned subsidiary bioengineering Center (accounting for 5% of the total share capital of Daan Gene Co.Ltd(002030) ) to its direct holding free of charge.
After this equity change, the information disclosure obligor will directly hold Daan Gene Co.Ltd(002030) 70172302 shares, accounting for 5% of the total share capital of Daan Gene Co.Ltd(002030) ; Indirectly holding Daan Gene Co.Ltd(002030) 233391995 shares through Guangzhou Zhongda Holding Co., Ltd., accounting for 16.63% of the total share capital of Daan Gene Co.Ltd(002030) ; Indirectly holding Daan Gene Co.Ltd(002030) 140344607 shares through the bioengineering center, accounting for 10.00% of the total share capital of Daan Gene Co.Ltd(002030) ; In conclusion, the shares of Daan Gene Co.Ltd(002030) controlled by the information disclosure obligor remain unchanged, with a total of 443908904 shares. The types of shares are non tradable A shares, accounting for 31.63% of the total share capital of Daan Gene Co.Ltd(002030) .
After this equity change, the information disclosure obligor is still the indirect controlling shareholder of the listed company. The details of the shares held by the information disclosure obligor before and after the equity change are as follows:
Unit: shares;%
Before and after transfer
Direct shareholding indirect shareholding
name
Number of shares ratio of shares to number of shares ratio of shares to number of shares ratio of shares to number of shares
biology
Project 210516909 15.00 — 140344607 10.00 —
Central Guangzhou
Financial holding – 443908904 31.63 70172302 5.00 373736602 26.63 group
remarks:
1. Indirect shareholding of Guangzhou financial holding group includes its indirect holding of Daan Gene Co.Ltd(002030) shares through its wholly-owned subsidiaries Guangzhou Zhongda Holding Co., Ltd. and Guangzhou bioengineering Center Co., Ltd. (including the shares lent by refinancing securities lending business);
2. The Daan Gene Co.Ltd(002030) shares held by Guangzhou bioengineering Center Co., Ltd. include the shares lent by refinancing securities lending business. 2、 Authorization and approval of the implementation of this equity change
As of the signing date of this report, the main decision-making and approval procedures for this equity change are as follows: on January 10, 2022, Guangzhou financial holding group held a board meeting to consider and approve the transfer of Daan Gene Co.Ltd(002030) 5% shares directly held by bioengineering center to Guangzhou financial holding group.
On January 14, 2022, Guangzhou financial holding group issued the notice of Guangzhou financial holding group on matters related to the free transfer of Daan Gene Co.Ltd(002030) 5% state-owned shares held by Guangzhou bioengineering Center Co., Ltd. (Guangzhou financial holding [2022] No. 9) to the bioengineering center.
On January 17, 2022, the bioengineering Center convened the board of directors to consider and approve the transfer of Daan Gene Co.Ltd(002030) 5% shares held by the bioengineering center to Guangzhou financial holding group.
